✦ LIBER ✦

Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole

✍ Scribed by Emilio Alba; Antonio Llombart; Nuria Ribelles; Manuel Ramos; Roberto Fernández; José Ignacio Mayordomo; Ignasi Tusquets; Miguel Gil; Agustí Barnadas; Francisco Carabante; Manuel Ruiz; Ruth Vera; Isabel Palomero; Vicente Soriano; Jesús González; Ramón Colomer

Book ID: 107596042
Publisher: Springer Milan
Year: 2006
Tongue: Spanish
Weight: 545 KB
Volume: 8
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-006-0010-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum YKL-40 levels as a prognostic fact

Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer

✍ Deniz Yamac; Banu Ozturk; Ugur Coskun; Ercument Tekin; Banu Sancak; Ramazan Yild 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 238 KB

Epidermal growth factor receptor serum (

Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR positive advanced colorectal cancer treated with gefitinib?

✍ M. G. Zampino; E. Magni; L. Santoro; L. Zorzino; P. Dell’Orto; A. Sonzogni; N. F 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 397 KB

Serum EGFR and serum HER-2/neu are usefu

Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy

✍ Maria Teresa Sandri; Harriet Ann Johansson; Laura Zorzino; Michela Salvatici; Ri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## BACKGROUND. Metronomic chemotherapy has been demonstrated to be of value in patients with advanced breast cancer. No reliable markers of response are available. In breast tumor, HER‐2/__neu__ is a prognostic factor, whereas no definite data exist for EGFR. The aim of the study was t

The Role of Serum CEA as a Prognostic In

The Role of Serum CEA as a Prognostic Indicator in Stage II and III Breast Cancer Patients Treated With Adjuvant Chemotherapy

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Herbert A. Fritsche; Debbie Frye; R 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Elevated serum levels of TPS and CYFRA 2

Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib

✍ Fengsheng Chen; Xi Luo; Jinbiao Zhang; Yang Lu; Rongcheng Luo 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 289 KB

Significance of serum carcinoembryonic a

Significance of serum carcinoembryonic antigen and CA 15-3 in monitoring advanced breast cancer patients treated with systemic therapy: A large-scale retrospective study

✍ Junichi Kurebayashi; Yutaka Yamamoto; Katsuhiro Tanaka; Norio Kohno; Masafumi Ku 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 646 KB